Literature DB >> 3276130

Combination therapy for cardiac arrhythmias.

S Lévy1.   

Abstract

Combinations of antiarrhythmic agents are often used when single agents are ineffective, only partly effective or poorly tolerated. The theoretical and experimental basis for combination therapy for arrhythmias is the dissimilar electrophysiologic properties of antiarrhythmic agents. Until more is known about the mechanism of drug synergism and drug interactions, the experience gained clinically remains essential to our understanding. Published reports contain numerous data on the effectiveness of various combinations of antiarrhythmic agents, including combinations of class I agents, the combination of a class I agent and a beta-blocking agent or amiodarone, and combinations including a calcium-antagonist agent. Adverse drug interactions, however, can occur, and combinations of certain agents must be avoided or used with caution.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3276130     DOI: 10.1016/0002-9149(88)90749-7

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  5 in total

1.  Efficacy of disopyramide and mexiletine used alone or in combination in the treatment of ventricular premature beats.

Authors:  H Sakurada; T Motomiya; M Hiraoka
Journal:  Cardiovasc Drugs Ther       Date:  1991-08       Impact factor: 3.727

Review 2.  Antiarrhythmic agents: drug interactions of clinical significance.

Authors:  T C Trujillo; P E Nolan
Journal:  Drug Saf       Date:  2000-12       Impact factor: 5.606

Review 3.  The value of oral amiodarone in the treatment of ventricular arrhythmias in heart disease.

Authors:  S Levy
Journal:  Drugs       Date:  1991       Impact factor: 9.546

4.  Effects of combined use of class I antiarrhythmic agents on Vmax of guinea-pig ventricular muscles.

Authors:  J Toyama; T Kawamura; I Kodama
Journal:  Cardiovasc Drugs Ther       Date:  1991-08       Impact factor: 3.727

5.  Combined effects of different class I antiarrhythmic agents on maximum rate of depolarization (Vmax) of action potentials in guinea-pig papillary muscles.

Authors:  M Hiraoka; J Nitta; A Sunami; T Sawanobori
Journal:  Cardiovasc Drugs Ther       Date:  1991-08       Impact factor: 3.727

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.